عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Drugs Public Price List 2016

Drugs Prices According to the Exchange Rate Issued on 9/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016   (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016  (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 20/11/2016 to 3/12/2016 .
 
Drugs Prices According to the Exchange Rate Issued on 1/12/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 6/11/2016 to 19/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 11/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 23/10/2016 to 5/11/2016.
 
Drugs Prices According to the Exchange Rate Issued on 1/11/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 9/10/2016 to 22/10/2016.
 
Drugs Prices According to the Exchange Rate Issued on 17/10/2016
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016  (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016 (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016
  • Table of Discounts: of conversion of the selling prices in the country of origin into comparison price US dollars according to the following foreign currency rates: average of the weeks: 25/9/2016 to 8/10/2016.
    1
    ...
    147
    148
    149
    150
    151
    152
    ...
    200
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
C10AA08 PIVAL G Pitavastatin - 2mg 2mg Tablet 802,466 L.L
C10AA08 LIVAZO B Pitavastatin - 4mg 4mg Tablet, film coated 1,835,305 L.L
C10AA08 PIVAL G Pitavastatin - 4mg 4mg Tablet 1,265,772 L.L
N02CX01 APIZINE G Pizotifen - 0.25mg/5ml 0.25mg/5ml Syrup 505,541 L.L
B02BD04 OCTANINE F BioHuman Plasma coagulation factor IX, human - 500IU 500IU Injectable freeze dried powder + diluent 13,114,263 L.L
B02BD04 IMMUNINE BioHuman Plasma coagulation factor IX, human - 600IU 600IU Injectable lyophilised powder for solution+diluent 8,557,621 L.L
B02BD04 IMMUNINE BioHuman Plasma coagulation factor IX, human - 600IU 600IU Injectable lyophilised powder for solution+diluent 20,506,214 L.L
L03AX16 MOZOBIL B Plerixafor - 20mg/ml 20mg/ml Injectable solution 6,787,349 L.L
L03AX16 REVIXIL 20 G Plerixafor - 20mg/ml 20mg/ml Injectable solution 4,072,411 L.L
L03AX16 MOZOBIL B Plerixafor - 20mg/ml 20mg/ml Injectable solution 413,801,327 L.L
L03AX16 REVIXIL 20 G Plerixafor - 20mg/ml 20mg/ml Injectable solution 248,280,900 L.L
J07AL02 PNEUMOSIL (10-VALENT) G Pneumococcal polysaccharide conjugate vaccine (adsorbed) - Injectable suspension 3,386,483 L.L
J07AL02 VAXNEUVANCE B Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 22F, 23F,33F (2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg) Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate adjuvant - Injectable suspension 6,988,413 L.L
J07AL02 PREVENAR 20 B Pneumococcal polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F,8, 9V,10A, 11A, 12F, 14, 15B, 18C, 19A, 19F,22F, 23F, 33F (2.2mcg) Pneumococcal polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein (approximately 51mcg) adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 7,415,107 L.L
C05BB02 AETHOXYSKLEROL B Polidocanol (Lauromacrogol 400) - 0.5% 0.5% Injectable solution 1,441,943 L.L
C05BB02 AETHOXYSKLEROL B Polidocanol (Lauromacrogol 400) - 1% 1% Injectable solution 1,732,213 L.L
C05BB02 AETHOXYSKLEROL B Polidocanol (Lauromacrogol 400) - 3% 3% Injectable solution 2,576,146 L.L
J07BF03 POLIOMYELITIS VACCINE INACTIVATED B Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U Injectable suspension 1,206,771 L.L
J07CA06 PENTAXIM B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 2,558,676 L.L
J07CA06 INFANRIX IPV + HIB B Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg Injectable dry powder+suspension 3,014,239 L.L
M01AH07 ACELEX B Polmacoxib - 2mg 2mg Capsule 2,600,655 L.L
J07AL02 PREVENAR 13 B Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) - Injectable suspension 6,863,004 L.L
J07AL02 SYNFLORIX B Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg Injectable suspension 4,675,228 L.L
J07AH08 NIMENRIX B Polysaccharide of Neisseria meningitidis (serogroups A, C, Y and W-135) conjugated - 5mcg/0.5ml, Tetanus toxoid carrier protein - 44mcg/0.5ml Injectable lyophilised powder for solution+diluent 4,483,059 L.L
J07AL01 PNEUMOVAX 23 B Polysaccharides from each of 23 capsular types of Streptococcus pneumoniae - 25mcgx23serotypes/0.5ml Injectable solution 2,409,510 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 10,462,270 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 1mg 1mg Capsule, hard 637,848,621 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 10,462,270 L.L
    1
    ...
    147
    148
    149
    150
    151
    152
    ...
    200
Sitemap
© Copyrights reserved to Ministry of Public Health 2024